Tri-complex inhibitors of the oncogenic, GTP-bound form of KRASG12C overcome RTK-mediated escape mechanisms and drive tumor regressions in vivo

Christopher J. Schulze, Alun Bermingham, Tiffany J. Choy, James J. Cregg, Gert Kiss, Abby Marquez, Denise Reyes, Mae Saldajeno-Concar, Caroline E. Weller, Daniel M. Whalen, Yu C. Yang, Elena S. Koltun, Robert J. Nichols, Mallika Singh, David Wildes, Adrian L. Gill, Richard L. Hansen, Steve Kelsey, Mark A. Goldsmith, Jacqueline A. M. Smith